Avidity Partners Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.86M | Buy |
|
|||||
|
2025
Q1 | $8.98M | Sell |
|
|||||
|
2024
Q4 | $15.9M | Sell |
|
|||||
|
2024
Q3 | $26.6M | Sell |
|
|||||
|
2024
Q2 | $30.3M | Sell |
|
|||||
|
2024
Q1 | $34.4M | Sell |
|
|||||
|
2023
Q4 | $36.6M | Buy |
|
|||||
|
2023
Q3 | $20.7M | Sell |
|
|||||
|
2023
Q2 | $39.2M | Sell |
|
|||||
|
2023
Q1 | $38.2M | Sell |
|
|||||
|
2022
Q4 | $51.7M | Sell |
|
|||||
|
2022
Q3 | $68.7M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $29.4M | Sell |
|
|||||
|
2021
Q4 | $29.3M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $8.41M | Sell |
|
|||||
|
2020
Q2 | $33.3M | Buy |
|
|||||
|
2020
Q1 | $11.6M | Buy |
|